Triphenylmethyl derivatives enhances the anticancer effect of immunotoxins

Journal of Immunotherapy

Volumn 34, Issue 5, 2011, Pages 438-447

  Risberg, Karianne ^a   Guldvik, Ingrid Jenny ^a   Palchaudhuri, Rahul ^b   Xi, Yaguang ^c   Ju, Jingfang ^d   Fodstad, Øystein ^a   Hergenrother, Paul J ^b   Andersson, Yvonne ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c UNIVERSITY OF SOUTH ALABAMA   (United States)

^d STONY BROOK UNIVERSITY   (United States)

Author keywords

apoptosis; immunotoxin; protein synthesis; stearoyl CoA desaturase; triphenylmethyl derivatives

Indexed keywords

ACYL COENZYME A DESATURASE; EPIDERMAL GROWTH FACTOR RECEPTOR; EXOTOXIN A 425.3; EXOTOXIN A 9.2.27; IMMUNOTOXIN; MONOUNSATURATED FATTY ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; SATURATED FATTY ACID; TRIPHENYLMETHYLPHOSPHONATES AND PHOSPHONOCHLORIDATE 4BI; TRIPHENYLMETHYLPHOSPHONATES AND PHOSPHONOCHLORIDATE I 2; TRITYL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN CELL; MALE; MICROMETASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PSEUDOMONAS; RAT; SURVIVAL RATE; UTERINE CERVIX CANCER;

ADP RIBOSE TRANSFERASES; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BACTERIAL TOXINS; BREAST NEOPLASMS; CASPASE 3; CELL LINE, TUMOR; CELL MEMBRANE; CELL SURVIVAL; DRUG SYNERGISM; EXOTOXINS; FEMALE; HUMANS; IMMUNOTOXINS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PHOSPHONIC ACIDS; POLY(ADP-RIBOSE) POLYMERASES; RATS; RATS, NUDE; RECEPTOR, EPIDERMAL GROWTH FACTOR; SKIN NEOPLASMS; STEAROYL-COA DESATURASE; TRITYL COMPOUNDS; UTERINE CERVICAL NEOPLASMS; VIRULENCE FACTORS;

EID: 79957903644     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/CJI.0b013e31821e00ae     Document Type: Article

References (39)

1. Andersson Y, Juell S, Fodstad O. Downregulation of the antiapoptotic MCL-1 protein and apoptosis in MA-11 breast cancer cells induced by an anti-epidermal growth factor receptor-pseudomonas exotoxin a immunotoxin. Int J Cancer. 2004;112:475-483. (Pubitemid 39390614)
2. Kreitman RJ, Pastan I. Immunotoxins in the treatment of hematologic malignancies. Curr Drug Targets. 2006;7: 1301-1311. (Pubitemid 44509694)
3. Risberg K, Fodstad O, Andersson Y. The melanoma specific 9.2.27PE immunotoxin efficiently kills melanoma cells in vitro. Int J Cancer. 2009;25:23-33.
4. Andersson Y, Engebraaten O, Fodstad O. Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo. Br J Cancer. 2009;101:1307-1315.
5. Engebraaten O, Sivam G, Juell S, et al. Systemic immunotoxin treatment inhibits formation of human breast cancer metastasis and tumor growth in nude rats. Int J Cancer. 2000;88: 970-976.
6. Hjortland GO, Garman-Vik SS, Juell S, et al. Immunotoxin treatment targeted to the high-molecular-weight melanoma-associated antigen prolonging the survival of immunodeficient rats with invasive intracranial human glioblastoma multiforme. J Neurosurg. 2004;100:320-327. (Pubitemid 38140237)
7. Dothager RS, Putt KS, Allen BJ, et al. Synthesis and identification of small molecules that potently induce apoptosis in melanoma cells through G1 cell cycle arrest. J Am Chem Soc. 2005;127:8686-8696. (Pubitemid 40868251)
8. Benzaquen LR, Brugnara C, Byers HR, et al. Clotrimazole inhibits cell proliferation in vitro and in vivo. Nat Med. 1995; 1:534-540.
9. Snajdrova L, Xu A, Narayanan N. Clotrimazole, an anti-mycotic drug, inhibits the sarcoplasmic reticulum calcium pump and contractile function in heart muscle. J Biol Chem. 1998;273:28032-28039. (Pubitemid 28496096)
10. Palchaudhuri R, Nesterenko V, Hergenrother PJ. The complex role of the triphenylmethyl motif in anticancer compounds. J Am Chem Soc. 2008;130:10274-10281.
11. Uddin MK, Reignier SG, Coulter T, et al. Syntheses and antiproliferative evaluation of oxyphenisatin derivatives. Bioorg Med Chem Lett. 2007;17:2854-2857. (Pubitemid 46636246)
12. Skoufias DA, DeBonis S, Saoudi Y, et al. S-trityl-L-cysteine is a reversible, tight binding inhibitor of the human kinesin Eg5 that specifically blocks mitotic progression. J Biol Chem. 2006; 281:17559-17569. (Pubitemid 44035555)
13. Scaglia N, Igal RA. Inhibition of Stearoyl-CoA Desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis. Int J Oncol. 2008;33:839-850.
14. Godal A, Kumle B, Pihl A, et al. Immunotoxins directed against the high-molecular-weight melanoma-associated antigen. Identification of potent antibody-toxin combinations. Int J Cancer. 1992;52:631-635.
15. Rye PD, Norum L, Olsen DR, et al. Brain metastasis model in athymic nude mice using a novel MUC1-secreting human breast-cancer cell line, MA11. Int J Cancer. 1996;68:682-687. (Pubitemid 26414532)
16. Micci F, Teixeira MR, Heim S. Complete cytogenetic characterization of the human breast cancer cell line MA11 combining G-banding, comparative genomic hybridization, multicolor fluorescence in situ hybridization, RxFISH, and chromosome-specific painting. Cancer Genet Cytogenet. 2001; 131:25-30. (Pubitemid 33081154)
17. Fodstad O, Kjonniksen I. Microenvironment revisited: time for reappraisal of some prevailing concepts of cancer metastasis. J Cell Biochem. 1994;56:23-28. (Pubitemid 24288106)
18. Xi Y, Riker A, Shevde-Samant L, et al. Global comparative gene expression analysis of melanoma patient samples, derived cell lines and corresponding tumor xenografts. Cancer Geno-mics Proteomics. 2008;5:1-35. (Pubitemid 351363372)
19. Oesterreich S, Lee AV, Sullivan TM, et al. Novel nuclear matrix protein HET binds to and influences activity of the HSP27 promoter in human breast cancer cells. J Cell Biochem. 1997;67:275-286. (Pubitemid 27431172)
20. Lee YB, Colley S, Norman M, et al. SAFB re-distribution marks steps of the apoptotic process. Exp Cell Res. 2007; 313:3914-3923. (Pubitemid 47566378)
21. Luan J, Shattuck-Brandt R, Haghnegahdar H, et al. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J Leukoc Biol. 1997;62:588-597. (Pubitemid 27519769)
22. Wang B, Hendricks DT, Wamunyokoli F, et al. A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer. Cancer Res. 2006;66:3071-3077.
23. Garcia-Peydro M, De Yebenes VG, Toribio ML. Notch1 and IL-7 receptor interplay maintains proliferation of human thymic progenitors while suppressing non-T cell fates. J Immunol. 2006;177:3711-3720. (Pubitemid 44359903)
24. Ohta T, Iijima K, Miyamoto M, et al. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res. 2008;68:1303-1309. (Pubitemid 351346836)
25. Hengartner MO. The biochemistry of apoptosis. Nature. 2000; 407:770-776.
26. Soengas MS, Lowe SW. Apoptosis and melanoma chemor-esistance. Oncogene. 2003;22:3138-3151.
27. Scaglia N, Chisholm JW, Igal RA. Inhibition of stearoylCoA desaturase-1 inactivates acetyl-CoA carboxylase and impairs proliferation in cancer cells: role of AMPK. PloS One. 2009; 4:e6812.
28. Igal RA. Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer. Carcinogenesis. 2010;31:1509-1515.
29. Scaglia N, Caviglia JM, Igal RA. High stearoyl-CoA desa-turase protein and activity levels in simian virus 40 trans-formed-human lung fibroblasts. Biochim Biophys Acta. 2005; 1687:141-151. (Pubitemid 40228994)
30. Li J, Ding SF, Habib NA, et al. Partial characterization of a cDNA for human stearoyl-CoA desaturase and changes in its mRNA expression in some normal and malignant tissues. Int J Cancer. 1994;57:348-352. (Pubitemid 24168608)
31. Fritz V, Benfodda Z, Rodier G, et al. Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice. Mol Cancer Ther. 2010;9:1740-1754.
32. Scaglia N, Igal RA. Stearoyl-CoA desaturase is involved in the control of proliferation, anchorage-independent growth, and survival in human transformed cells. J Biol Chem. 2005;280: 25339-25349. (Pubitemid 40962236)
33. Kato H, Sakaki K, Mihara K. Ubiquitin-proteasome-depen-dent degradation of mammalian ER stearoyl-CoA desaturase. J Cell Sci. 2006;119:2342-2353. (Pubitemid 43960323)
34. Leger S, Black WC, Deschenes D, et al. Synthesis and biological activity of a potent and orally bioavailable SCD inhibitor (MF-438). Bioorg Med Chem Lett. 2010;20:499-502.
35. Minville-Walz M, Pierre AS, Pichon L, et al. Inhibition of stearoyl-CoA desaturase 1 expression induces CHOP-dependent cell death in human cancer cells. PloS One. 2010;5:e14363.
36. Hess D, Chisholm JW, Igal RA. Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells. PloS One. 2010;5:e11394.
37. Laezza C, Malfitano AM, Di Matola T, et al. Involvement of Akt/NF-kappaB pathway in N(6)-isopentenyladenosine-induced apoptosis in human breast cancer cells. Mol Carcino-genesis. 2010;49:892-901.
38. Hosoi T, Hyoda K, Okuma Y, et al. Akt up-and down-regulation in response to endoplasmic reticulum stress. Brain Res. 2007;1152:27-31. (Pubitemid 46802507)
39. Morgan-Lappe SE, Tucker LA, Huang X, et al. Identification of Ras-related nuclear protein, targeting protein for xenopus kinesin-like protein 2, and stearoyl-CoA desaturase 1 as promising cancer targets from an RNAi-based screen. Cancer Res. 2007;67:4390-4398. (Pubitemid 46815088)